NDAINJECTIONINJECTABLE
Approved
Oct 1962
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
DECA-DURABOLIN (nandrolone decanoate) by Teva is clinical pharmacology anabolic steroids are synthetic derivatives of testosterone. First approved in 1962.
Drug data last refreshed 1h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DECA-DURABOLIN (nandrolone decanoate) is a synthetic anabolic steroid derivative of testosterone administered via intramuscular injection. It works by mimicking male sex hormones to promote anabolic effects including increased protein synthesis and muscle mass. The drug is indicated for specific clinical conditions requiring anabolic support, though its use is heavily restricted due to androgenic side effects and abuse potential.
LOE Approaching
As LOE approaches, the brand team will likely downsize with focus shifting to cost management and generic transition planning rather than growth initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Anabolic steroids are synthetic derivatives of testosterone. Certain clinical effects and adverse reactions demonstrate the androgenic properties of this class of drugs. Complete dissociation of anabolic and androgenic effects has not been achieved. The actions of anabolic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
38 enrolled
HIV InfectionsHIV Wasting Syndrome
Career Relevance
Working on DECA-DURABOLIN offers limited career growth due to its LOE status and mature lifecycle; opportunities are primarily defensive and focused on regulatory compliance, cost management, and generic transition. This role is best suited for professionals seeking stability in a declining portfolio asset rather than expansion and innovation.
Worked on DECA-DURABOLIN at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.